Workflow
2025年中国宠物药物白皮书
沙利文·2025-01-21 23:23

Investment Rating - The report does not explicitly provide an investment rating for the pet pharmaceutical industry Core Insights - The Chinese pet pharmaceutical industry is experiencing significant growth driven by increasing pet ownership and heightened awareness of pet health among owners [7][12] - Domestic pet pharmaceuticals are becoming a cornerstone of the market, characterized by improved quality, innovation, and alignment with local market needs [58] - The market is projected to grow from 93.9 billion yuan in 2020 to 209.5 billion yuan by 2024, with a compound annual growth rate (CAGR) of 22.2% [55][57] Summary by Sections Chapter 1: The Golden Era of Pet Healthcare in China - The role of pets has evolved from mere companions to integral family members, leading to increased focus on their health [11][12] - Pet owners are willing to invest more in professional healthcare services, including high-quality medications and medical procedures [16] Chapter 2: The Rise of Domestic Pet Pharmaceuticals - Domestic pet pharmaceuticals are gaining traction due to enhanced quality and innovation, becoming a vital part of the pet healthcare market [58] - The internationalization of Chinese pet pharmaceuticals is underway, with companies meeting global standards for quality and safety [58] Chapter 3: Competition Among Domestic Pet Pharmaceutical Brands - The competitive landscape is marked by brands focusing on increasing offline store coverage, product variety, and pricing strategies [9][75] - The report highlights the importance of offline store presence as a key competitive factor in the domestic pet pharmaceutical market [75] Market Size and Growth - The pet pharmaceutical market in China is expected to reach 354.1 billion yuan by 2029, with a projected CAGR of 10.4% from 2025 to 2028 [55][57] - The number of pet clinics is anticipated to grow from 26,000 in 2024 to 44,000 by 2029, reflecting a CAGR of 10.4% [45][46] Domestic Brand Development - Domestic brands are increasingly recognized for their high cost-performance ratio, making them the preferred choice for veterinary institutions [69] - The report emphasizes the establishment of strong partnerships between domestic brands and veterinary clinics, enhancing service quality and brand loyalty [71][73]